genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Receptor tyrosine kinases
Cancer
CTI Regains Rights to Pacritinib from Baxalta
Industry News
Regeneron, Ocular Therapeutix to Develop Sustained-Release Aflibercept Formulation
Cancer
BMS Reacquires Asian Rights to Aslan’s Solid-Tumor Candidate
Cancer
New Approach Described for Eliminating Cancer Stem Cells
Cancer
Tivozanib Strikes Out: Aveo, Astellas End Collaboration
Insights
Culturing Primary Cells
News
Royalty Pharma Buys Quest Cancer Candidate Royalty Rights for $485M
Cancer
Firms Partner on Global Development of China-Approved Chemotherapy
Cancer
Studies Show JAK1/2 Inhibition Increases Tumor Cell Susceptibility to NK-Mediated Lysis
Cancer
ImmunoCellular Therapeutics Gains Rights to Target EphA2 from University of Pittsburgh
1
2
3
4
...
6
Page 3 of 6
Scroll Up